Search
Sunday 9 August 2015
  • :
  • :
Latest Update

Pre-Market News Report on: Enterprise Products Partners (NYSE:EPD), Qorvo (NASDAQ:QRVO), Ironwood Pharmaceuticals, (NASDAQ:IRWD), Carnival (NYSE:CCL)

On Monday, Enterprise Products Partners L.P. (NYSE:EPD)’s shares declined -3.53% to $27.33.

Enterprise Products Partners L.P. (EPD) declared its financial results for the three and six months ended June 30, 2015.

  • Enterprise raised its cash distribution with respect to the second quarter of 2015 by 5.6 percent to $0.38 per unit contrast to the second quarter of 2014;
  • Enterprise stated distributable cash flow of $988 million for the second quarter of 2015, which offered 1.3 times coverage of the $0.38 per unit cash distribution and resulted in $238 million of retained distributable cash flow; and
  • Associates of privately held Enterprise Products Company (“EPCO”), which collectively own our general partner and about 34 percent of our outstanding limited partner interests, purchased $50 million of common units from Enterprise in May 2015 through the distribution reinvestment plan. Counting this purchase, EPCO associates have purchased $150 million of Enterprise common units in 2015.

Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products in the United States and internationally. Its NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, in addition to import and export terminal services.

Qorvo Inc (NASDAQ:QRVO)’s shares dropped -0.74% to $57.52.

Qorvo(TM) (QRVO), a leading provider of core technologies and RF solutions for mobile, infrastructure and aerospace/defense applications, recently declared financial results for its fiscal 2016 first quarter, ended June 27, 2015.

On a GAAP basis, June quarterly revenue was $673.6 million and gross margin was 41.5%, operating loss was ($1.3) million, and net income was $2.0 million, or $0.01 per diluted share based on 154.5 million shares outstanding.

On a non-GAAP basis, June quarterly revenue was $672.7 million and gross margin was 51.5%. Synergies realized in G&A were balanced by higher investments in R&D, yielding operating income of $187.8 million, or 27.9% of sales. Net income was $168.5 million, or $1.09 per diluted share based on 154.5 million shares outstanding.

Qorvo, Inc. provides technologies and radio frequency (RF) solutions for mobile, infrastructure, defense, and aerospace applications in the United States and internationally. The company operates through Mobile Products, and Infrastructure and Defense Products segments. The Mobile Products segment offers complete RF front end modules that combine high-performance filters, power amplifiers (PAs) and switches, PA modules, transmit modules, antenna control solutions, antenna switch modules, diversity receive modules, and envelope tracking power administration devices.

At the end of Monday s trade, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)‘s shares surged 0.86% to $10.54

Ironwood Pharmaceuticals, Inc. (IRWD) declared positive top-line data from a Phase I study of IW-1973, its lead investigational soluble guanylate cyclase (sGC) stimulator. In the study, IW-1973 demonstrated cardiovascular pharmacodynamic effects, extensive tissue distribution, proof of mechanism for sGC stimulation, and a dose range that was well tolerated in healthy volunteers. The totality of clinical and preclinical data generated to date strongly support continued development of IW-1973 as a potential once-daily oral therapy.

Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Constella name in the European Union.

Carnival Corp (NYSE:CCL), ended its Monday’s trading session with -2.03% loss, and closed at $52.21.

Seabourn has revealed the rendering of one of the most distinct onboard venues aboard its newest ultra-luxury vessel, Seabourn Encore, debuting in December 2016: the Grand Salon. Custom tailored with striking elements by design icon Adam D. Tihany, who is designing all of the indoor and outdoor areas aboard Seabourn Encore, the main show lounge will present a sophisticated setting for onboard performances, from new shows by seasoned entertainers to local, cultural productions from ashore and engaging guest speakers from the line’s popular enrichment series, Seabourn Conversations, such as legendary American journalist Dan Rather and Forbes Media Chairman and Editor-in-Chief Steve Forbes.

Carnival Corporation operates as a cruise company worldwide. It provides vacations to various cruise destinations. The company offers cruise services under the Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn brand names in North America; and AIDA Cruises, Costa Cruises, Cunard, and P&O Cruises names in Europe, Australia, and Asia. It operates 100 cruise ships. It also owns and operates 12 hotels or lodges, and about 300 motor coaches and 20 glass-domed railcars.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *